Literature DB >> 12811214

Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy.

Tamer Atassi1, Paul J Thuluvath.   

Abstract

BACKGROUND: Immunosuppression following solid organ transplantation has been associated with a higher prevalence of cancers including colon cancer. However, the risk of colorectal adenoma following liver transplantation is unknown. The objective of this pilot study is to determine whether the prevalence of colorectal adenoma is increased in liver transplant recipients.
METHODS: In this retrospective study, 25 patients who had liver transplantation at our institution between 1994 to 1997 and who underwent routine posttransplantation colonoscopy were compared with 50 controls who were undergoing routine screening colonoscopy. Transplant recipients who were younger than 45 years, survived less than 3 years following liver transplant, with history of inflammatory bowel disease, or prior history of colonic adenoma or cancer were excluded from the study. In both groups, colonoscopic diagnosis of polyp was confirmed by pathologic diagnosis of adenoma on biopsy.
RESULTS: 25 (12M/13F, mean age 53 +/- 7 years) liver transplant recipients were compared with 50 controls (19M/31F, mean age of 59 +/- 7 years). In transplant recipients, colonoscopy was performed 41 +/- 19 months after liver transplantation. Seven (28%) liver transplant recipients (5M, 2F) and 4 (8%) controls (3F, 1M) were found to have adenomatous polyp (OR 4.5, 95% CI 1-21.2, P = 0.049). Malignant polyps were not detected in both groups.
CONCLUSION: Liver transplant recipients appear to have an increased risk for developing colorectal adenoma. Early screening colonoscopy is warranted for this group of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12811214     DOI: 10.1097/00004836-200307000-00018

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

1.  Outcomes of colorectal cancer arising in solid organ transplant recipients.

Authors:  Amit Merchea; Zaid M Abdelsattar; Timucin Taner; Patrick G Dean; Dorin T Colibaseanu; David W Larson; Eric J Dozois
Journal:  J Gastrointest Surg       Date:  2013-11-20       Impact factor: 3.452

Review 2.  Accelerated Premalignant Polyposis and Second Colon Cancers: Incriminating Immunosuppression, Radiotherapy, and Systemic Chemotherapy Agents.

Authors:  Frank J Senatore; Shruti Murali; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2016-06

3.  Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients.

Authors:  Antonio Diaz-Sanchez; Oscar Nuñez-Martinez; Cecilia Gonzalez-Asanza; Ana Matilla; Beatriz Merino; Diego Rincon; Inmaculada Beceiro; Maria Vega Catalina; Magdalena Salcedo; Rafael Bañares; Gerardo Clemente
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

Review 4.  Incidence and management of colorectal cancer in liver transplant recipients.

Authors:  Taiga Nishihori; Mario Strazzabosco; Muhammad Wasif Saif
Journal:  Clin Colorectal Cancer       Date:  2008-07       Impact factor: 4.481

5.  Increased Risk of Advanced Colonic Adenomas and Timing of Surveillance Colonoscopy Following Solid Organ Transplantation.

Authors:  Motaz H Ashkar; Jacqueline Chen; Corey Shy; Jeffrey S Crippin; Chien-Huan Chen; Gregory S Sayuk; Nicholas O Davidson
Journal:  Dig Dis Sci       Date:  2021-05-10       Impact factor: 3.199

6.  Presentation of COVID-19 in a liver transplant recipient.

Authors:  Behzad Hatami; Pardis Ketabi Moghadam; Mohammadreza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.